翻新医疗成像设备市场

The secondary research process involved comprehensive analysis of regulatory databases, peer-reviewed medical journals, clinical publications, and authoritative health organizations. Key sources included the US Food & Drug Administration (FDA), European Medicines Agency (EMA), International Atomic Energy Agency (IAEA), World Health Organization (WHO) Medical Device Regulations, National Electrical Manufacturers Association (NEMA), Medical Imaging & Technology Alliance (MITA), European Coordination Committee of the Radiological, Electromedical and Healthcare IT Industry (COCIR), Organization for Economic Co-operation and Development (OECD) Health Statistics, National Institutes of Health (NIH) National Center for Biotechnology Information (NCBI/PubMed), Centers for Medicare & Medicaid Services (CMS), European Commission Medical Device Coordination Group (MDCG), Health Canada, Therapeutic Goods Administration (TGA) Australia, Pharmaceuticals and Medical Devices Agency (PMDA) Japan, China National Medical Products Administration (NMPA), and national health ministry reports from key markets. These sources were used to collect equipment installation statistics, regulatory approval data, refurbishment certification standards, healthcare infrastructure trends, and market landscape analysis for MRI machines, CT scanners, ultrasound systems, X-ray machines, and other imaging modalities.

Additional authoritative sources included the American College of Radiology (ACR), Radiological Society of North America (RSNA), European Society of Radiology (ESR), International Society for Magnetic Resonance in Medicine (ISMRM), Society of Nuclear Medicine and Molecular Imaging (SNMMI), Association of Medical Imaging Management (AHRA), Healthcare Information and Management Systems Society (HIMSS), and World Bank Health, Nutrition and Population Statistics. Trade associations such as the Advanced Medical Technology Association (AdvaMed), Medical Device Manufacturers Association (MDMA), and Japan Federation of Medical Devices Associations (JFMDA) provided industry-specific data on equipment lifecycle management and secondary market dynamics.

Qualitative and quantitative insights were obtained by interviewing supply-side and demand-side stakeholders during the primary research process. The supply-side sources consist of CEOs, VPs of Operations, refurbishment center directors, regulatory compliance chiefs, and commercial directors from original equipment manufacturers (OEMs), third-party refurbishers, and medical equipment leasing companies. The demand-side sources consists of chief radiologists, biomedical equipment managers, procurement directors from hospitals and health systems, diagnostic center administrators, and capital planning executives from academic medical centers and integrated delivery networks (IDNs). The primary research validated market segmentation across equipment types (MRI, CT, ultrasound, X-ray), confirmed refurbishment pipeline timelines, and garnered insights on equipment replacement cycles, total cost of ownership analysis, and financing/leasing dynamics.

Primary Respondent Breakdown:

By Designation: C-level Primaries (28%), Director Level (35%), Others (37%)

By Region: North America (32%), Europe (30%), Asia-Pacific (28%), Rest of World (10%)

Global market valuation was derived through revenue mapping and equipment installation base analysis. The methodology included:

Identification of 60+ key manufacturers and refurbishment service providers across North America, Europe, Asia-Pacific, and Latin America

Product mapping across MRI machines, CT scanners, ultrasound systems, X-ray machines, and other imaging modalities (PET/CT, SPECT, mammography)

Analysis of reported and modeled annual revenues specific to refurbished equipment portfolios and refurbishment services

Coverage of manufacturers and refurbishers representing 75-80% of global market share in 2024

Extrapolation using bottom-up (installed base × refurbishment rate × ASP by country) and top-down (manufacturer/refurbisher revenue validation) approaches to derive segment-specific valuations

Cross-validation with import/export data for used and refurbished medical equipment from customs databases and trade statistics

The market size estimation incorporated unit shipment data, average selling prices (ASPs) by equipment age and condition tier (cosmetically refurbished vs. fully refurbished with parts replacement), and regional pricing differentials. Equipment lifecycle analysis was performed to estimate replacement demand and secondary market supply dynamics.